Cardio Diagnostics Holdings Inc. Common stock (CDIO) Stock Price

CDIOStock

$1.91−47.69%52W

Market Cap$5.65M

P/E—

PEG Ratio—

Div yield—

Beta2.30

CDIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.87%

Price vs S&P 500 (4W)20.35%

VGM Score60.16

Book Value / Share (Quarterly)$3.01

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-2.14

Price vs S&P 500 (YTD)-40.93%

Net Profit Margin (TTM)-40116.22%

EPS (TTM)$-3.38

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-3.38

EPS (Annual)$-3.71

ROI (Annual)-89.71%

Cash / Share (Quarterly)$2.39

Revenue Growth QoQ (YoY)185.11%

ROA (Last FY)-83.67%

Revenue Growth TTM (YoY)-16.68%

EBITD / Share (TTM)$-3.24

ROE (5Y Avg)-126.08%

Operating Margin (TTM)-40038.24%

Cash Flow / Share (Annual)$-3.37

P/B Ratio0.67x

P/B Ratio (Quarterly)0.65x

Net Income / Employee (Annual)$-433,200

EV / Revenue (TTM)-57.90x

Net Interest Coverage (TTM)-460.19x

ROA (TTM)-72.87%

EPS Incl Extra (Annual)$-3.71

Current Ratio (Annual)9.79x

Quick Ratio (Quarterly)14.41x

3-Month Avg Trading Volume0.07M

52-Week Price Return-47.69%

Revenue / Employee (TTM)$1,100

Tangible BV / Share (Quarterly)$2.69

P/S Ratio (Annual)401.11x

Asset Turnover (Annual)0.00x

52-Week High$7.91

EPS Excl Extra (Annual)$-3.71

CapEx CAGR (5Y)69.47%

26-Week Price Return-9.62%

Quick Ratio (Annual)8.46x

13-Week Price Return27.48%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)15.76x

Enterprise Value$-959,900

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,000

Pretax Margin (Annual)-43817.73%

Cash / Share (Annual)$2.80

3-Month Return Std Dev86.99%

Net Income / Employee (TTM)$-443,400

ROE (Last FY)-93.19%

Net Interest Coverage (Annual)-514.60x

EPS Basic Excl Extra (Annual)$-3.71

Receivables Turnover (TTM)2.40x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-3.38

Receivables Turnover (Annual)1.11x

ROI (TTM)-77.64%

P/S Ratio (TTM)358.78x

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$3.34

Price vs S&P 500 (52W)-66.00%

Year-to-Date Return-28.97%

5-Day Price Return0.79%

EPS Normalized (Annual)$-3.71

ROA (5Y Avg)-96.26%

Net Profit Margin (Annual)-43817.73%

Month-to-Date Return23.40%

EBITD / Share (Annual)$-3.66

Operating Margin (Annual)-43722.66%

ROI (5Y Avg)-114.91%

EPS Basic Excl Extra (TTM)$-3.38

P/TBV (Quarterly)0.72x

P/B Ratio (Annual)0.71x

Pretax Margin (TTM)-40116.22%

Book Value / Share (Annual)$3.82

Price vs S&P 500 (13W)24.69%

Beta2.30x

Revenue / Share (TTM)$0.01

ROE (TTM)-78.82%

52-Week Low$0.97

gGradeC

mGradeB

vgmGradeB

CDIO Earnings Surprise History

Q2 24-1.80est. -2.70

Q3 24-1.80est. -1.50

Q4 24-0.30est. -1.80

Q1 25-0.97est. -1.80

CDIO Analyst Recommendations

Jun 2025

Jul 2025

Aug 2025

Oct 2025

4.14

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc develops AI-powered epigenetics-based clinical tests for coronary heart disease risk assessment, detection, and management. The company's diagnostic platform combines epigenetic and genetic biomarkers to provide personalized clinical insights for healthcare providers. Its three main solutions—Epi+Gen CHD, PrecisionCHD, and Actionable Clinical Intelligence—enable better identification and management of patients at risk for coronary events.